BlackRock Institutional Trust’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPIX
AI
SCM
BCM
BA
BlackRock Institutional Trust's CPIX Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Cumberland Pharmaceuticals (CPIX) stake by 3.2% in Q4 2016, buying an estimated $61.6K and bringing the position to 381,679 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3035.
BlackRock Institutional Trust first reported a position in CPIX in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.99M in Q2 2013. 41 funds tracked by Wall St. Rank hold CPIX as of Q4 2016.
- BlackRock Institutional Trust held 381,679 shares of Cumberland Pharmaceuticals worth $2.1M as of Q4 2016.
- BlackRock Institutional Trust bought 11,802 Cumberland Pharmaceuticals shares in Q4 2016, an estimated $61.6K.
- Cumberland Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3035 holding.
- BlackRock Institutional Trust first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Cumberland Pharmaceuticals position peaked at $4.99M in Q2 2013.
- 41 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.